Amgen Inc. (AMG DU) stock market data APIs
€230.4308
2.75(1.2%)
as of September 15, 2025
Try our APIs with
free plan!
Amgen Inc. Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for AMG.DU.
Prev. Close
230.4308
Open
233.1853
High
237.5121
Low
230.4308
52 wk Range
226.6171-303.0415
Market Cap
105 182 M
Dividends (Yield)
0.0224
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Amgen Inc. data using free add-ons & libraries
Get Amgen Inc. Fundamental Data
Amgen Inc. Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Amgen Inc. News
New
Why California’s biopharma boom is critical for logistics
Building Resilience and Innovation: California’s Pharmaceutical Renaissance California is quietly staging a pharmaceutical renaissance, not of arts or culture this time, but of science, supply chai...
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
Amgen (AMGN) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near f...
Guggenheim Maintains a Hold on Amgen Inc. (AMGN)
Amgen Inc. (NASDAQ:AMGN) is one of the best cheap stocks to buy for beginners. In a report released on September 5, Vamil Divan from Guggenheim maintained a Hold rating on Amgen Inc. (NASDAQ:AMGN), se...
Amgen Inc (AMGN) Releases Top-Line Results From ASCEND Study of Rocatinlimab
Amgen Inc. (NASDAQ:AMGN) is one of the Blue Chip Stocks to Buy with the Lowest PE Ratios. On September 8, Amgen Inc. (NASDAQ:AMGN), along with Kyowa Kirin preliminary top-line results from the ASCEND ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
